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ABSTRACT
HUANG, T.-Y., F. R. GOLDSMITH, S. E. FULLER, J. SIMON, H. M. BATDORF, M. C. SCOTT, N. M. ESSAJEE, J. M. BROWN, D. H.
BURK, C. D. MORRISON, S. J. BURKE, J. J. COLLIER, AND R. C. NOLAND. Response of Liver Metabolic Pathways to Ketogenic Diet
and Exercise Are Not Additive.Med. Sci. Sports Exerc., Vol. 52, No. 1, pp. 37–48, 2020. Purpose: Studies suggest ketogenic diets (KD) pro-
duce favorable outcomes (health and exercise performance); however, most rodent studies have used a low-protein KD, which does not reflect the
normal- to high-proteinKDused by humans. Liver has an important role in ketoadaptation due to its involvement in gluconeogenesis and ketogenesis.
This study was designed to test the hypothesis that exercise training (ExTr) while consuming a normal-protein KD (NPKD) would induce additive/
synergistic responses in liver metabolic pathways.Methods: Lean, healthy male C57BL/6J mice were fed a low-fat control diet (15.9% kcal protein,
11.9% kcal fat, 72.2% kcal carbohydrate) or carbohydrate-deficient NPKD (16.1% protein, 83.9% kcal fat) for 6 wk. After 3 wk on the diet, half were
subjected to 3-wk treadmill ExTr (5 d·wk−1, 60min·d−1, moderate-vigorous intensity). Upon conclusion, metabolic and endocrine outcomes related to
substrate metabolismwere tested in liver and pancreas.Results:NPKD-fedmice had higher circulating β-hydroxybutyrate andmaintained glucose at
rest and during exercise. Liver ofNPKD-fedmice had lower pyruvate utilization and greater ketogenic potential as evidenced by higher oxidative rates
to catabolize lipids (mitochondrial and peroxisomal) and ketogenic amino acids (leucine). ExTr had higher expression of the gluconeogenic gene,
Pck1, but lower hepatic glycogen, pyruvate oxidation, incomplete fat oxidation, and total pancreas area. Interaction effects between the NPKD and
ExTr were observed for intrahepatic triglycerides, as well as genes involved in gluconeogenesis, ketogenesis, mitochondrial fat oxidation, and perox-
isomal markers; however, none were additive/synergistic. Rather, in each instance the interaction effects showed the NPKD and ExTr opposed each
other. Conclusions: An NPKD and an ExTr independently induce shifts in hepatic metabolic pathways, but changes do not seem to be additive/
synergistic in healthymice.KeyWords: PEROXISOMAL,MITOCHONDRIA, OXIDATION, NORMALPROTEIN, TRAINING, PANCREAS
Liver has a robust mitochondrial oxidative capacity andaccounts for nearly 25% of basal metabolic rate (1). Asignificant portion of the metabolic capacity of the liver
is dedicated to managing substrate availability for the body. In
this regard, the liver is unique because it plays a critical role in
substrate synthesis (gluconeogenesis, de novo lipogenesis, and
ketogenesis) while also having a high capacity for substrate
storage (glycogen and triglyceride [TAG]). The importance
of these hepatic functions becomes particularly evident under
conditions with significant shifts in fuel metabolism including
exercise, energy deprivation, and the postabsorptive state.
Acute exercise increases mitochondrial respiration, tricar-
boxylic acid cycle flux, and fat oxidation in liver (2–4). These
shifts in hepatic metabolism help support its role in the exercise
response to facilitate production of glucose and ketones that can
be used by skeletal muscle and heart to meet increased energy
demand (5–7). Exercise training (ExTr) can improve hepatic mi-
tochondrial function, increase fat utilization, and reduce hepatic
steatosis; however, this has been reported primarily in models
of liver disease (8–10), whereas less is known about adaptations
in healthy subjects. Identifying strategies that maximize health
benefits from ExTr is important for all populations. One such
area is modulating diet to optimize the effects of exercise.
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Ketogenic diets (KD) have gained attention in academic
and public health fields because reports indicate they impart
beneficial health effects including weight loss/maintenance,
increased energy expenditure, and improved glycemic control
(11–13). They have also become increasingly popular for ex-
ercise enthusiasts. A consistent theme of KD is that they con-
tain very low/no carbohydrate and this relative lack of a key
macronutrient can induce adaptations akin to states of energy
deficit (11,14). When carbohydrate supply is limited and insu-
lin levels are low, gluconeogenic pathways are activated and
hepatic mitochondria process fatty acids and certain amino
acids to produce ketones. This latter process, known as keto-
genesis, spares glucose by providing an alternative fuel source
for peripheral tissues (heart, brain, muscle, etc.). Because liver
plays an important role in gluconeogenesis and ketogenesis, it
is important to know how hepatic metabolic pathways adapt to
a KD and how this type of diet impacts exercise adaptations.
The principles of ketoadaptation suggest the body responds
to prolonged feeding of a KD by reprogramming metabolic
pathways to maximize lipid utilization while sparing use of
carbohydrate, which has been theorized to improve athletic
performance (15,16). Although this is still a topic of debate,
increasing evidence shows prolonged consumption of a KD
enhances in vivo fatty acid use during exercise and either
maintains or improves performance (16,17). These observa-
tions are largely derived from RER, which predominantly rep-
resents exercising skeletal muscle. Alternatively, there is little
information regarding hepatic adaptations under these condi-
tions. Therefore, we tested hepatic substrate metabolism path-
ways in lean, healthy mice that underwent an ExTr regimen
while being fed a KD. Importantly, although KD consistently
have a high fat content and very low/no carbohydrate, protein
content often varies. The majority of literature testing effects
of KD in rodents have used a low-protein KD (11,12,18–20),
which is less relevant to the type of KD usually consumed by
humans (16,17,21). As such, the KD used in this study contained
normal protein content (NPKD) that was matched to the control
diet to 1) more closely mimic KD used by humans, and 2) avoid
confounding metabolic adaptations that result from protein re-
striction (20,22,23). Primary goals of this study were to test the
interactive effects of a NPKD and ExTr on hepatic cellular en-
ergy sensing pathways, mitochondrial content, substrate oxida-
tive capacity (carbohydrate, amino acid, and lipid), peroxisomal
capacity, and endocrine parameters that regulate glucose ho-
meostasis including corticosterone and pancreatic hormones.
We hypothesized that ExTr and the NPKD diet would have
additive effects to expand hepatic oxidative capacity to utilize
ketogenic substrates (lipids and ketogenic amino acids), while
also remodeling pathways involved in carbohydrate metabo-
lism in liver and pancreas in a manner to spare glucose.
METHODS
Animals
C57BL/6J male mice were ordered from Jackson Laborato-
ries (Stock 000664; Bar Harbor, ME) at 12 wk of age and
studied at 20 wk of age. Mice were group-housed at room
temperature under a 12:12-h light:dark cycle and allowed
ad libitum access to food and water. The Pennington Biomed-
ical Research Center has an AALAC-approved Comparative
Biology Core facility and veterinary staff that monitor the
health of the animals via a sentinel program and daily inspec-
tion. All studies were approved by the Institutional Animal
Care and Use Committee.
Study Design
Figure 1A illustrates the study design. Two weeks after ar-
rival (14 wk old) body weight was measured and results were
used to assign mice into groups that ensured similar body
weight before beginning the dietary intervention. Control mice
(n = 20) were switched to a matched control diet (TestDiet
5TJS, St. Louis,MO) consisting of 15.9% calories from protein,
11.9% from fat, and 72.2% from carbohydrate. Alternatively,
mice in the experimental group (n = 19) were provided a
KD with no carbohydrate (NPKD; TestDiet 5TJQ, St. Louis,
MO), which provided 16.1% calories from protein (i.e., nearly
isocaloric to matched control diet) and 83.9% from fat. Again,
these are matched diets, meaning both were configured using
the same sources of protein (casein) and lipid (lard, milk fat, and
vegetable shortening), whereas carbohydrate (sucrose and malto-
dextrin) was only present in the matched control diet. Dietary
interventions were sustained for 6 wk. After 2.5 wk on the
diet, all mice (n = 39) were habituated on an Exer 3/6 treadmill
(Columbus Instruments; Columbus, OH) for 3 d. The tread-
mill was set at 10° incline and the habituation protocol
consisted of 5 min stages at 0, 5, 10 m·min−1 followed by
2 min at 15 m·min−1. All mice responded well to the habituation
protocol, so they were randomly assigned to the following groups:
control (low fat) sedentary (Con-Sed, n = 11), control (low fat)
ExTr (Con-ExTr, n = 9), NPKD sedentary (NPKD-Sed, n = 10),
or NPKD ExTr (NPKD-ExTr, n = 9) groups.
ExTr Protocol
The 3-wk training protocol was initiated after 3 wk on the die-
tary intervention (Fig. 1A).Mice in the ExTr groups were run on a
treadmill for 3 wk, 5 d·wk−1, 1 h·d−1 using a protocol designed to
recapitulate a moderate-to-high exercise intensity. Figure 1B
shows mice were trained on a treadmill set at 10° incline and each
session started with a 5-min warm-up, followed by a step-wise in-
crease in speed until 65 min to ensure mice reached the desired in-
tensity. To account for adaptations in fitness, exercise intensitywas
increased eachweek (Fig. 1B).Aversive stimuli (light tappingwith
a brush, light electrical shock)were used to ensuremice completed
each bout. Mice were monitored continuously, and the exercise
protocol was well-tolerated as none exhibited signs of exhaus-
tion (no righting reflex and/or acceptance of light electrical
shock for >5 s) or injury (awkward gait, foot injury, etc.).
Tissue Harvest
At the end of week 6, tissues were collected 24 h after the
last exercise bout and food was removed 3 h before harvest.









Tissue collection occurred between 9:00 AM and 11:00 AM and
mice were anesthetized via i.p. injection of ketamine/xylazine/
acepromazine (16 mg·mL−1 ketamine, 0.8 mg·mL−1 xylazine, and
0.32mg·mL−1 acepromazine delivered at a dose of 0.125mL/20 g
body weight). Trunk blood was obtained via decapitation and
allowed to clot at room temperature for 20 min. Serumwas then
isolated by centrifuging the blood at 2000g for 10 min at 4°C
and collecting the supernatant. Pancreatic tissue was fixed in
neutral-buffered formalin before embedding and sectioning.
Liver was collected and either 1) used fresh for substrate oxi-
dation assays, or 2) snap-frozen in liquid nitrogen and stored at
−80°C until subsequent analyses could be performed.
Bloodwork
Acute exercise responses for blood glucose (Accu-Chek
Aviva Plus Glucometer; Roche Diagnostic, Indianapolis, IN),
β-hydroxybutyrate (BHB) (Nova Blood Ketone Monitor; Nova
Biomedical, Waltham, MA), and lactate (Lactate Plus Meter;
Nova Biomedical, Waltham, MA) were measured via tail vein
in conscious mice before and after acute exercise at the end of
week 5 (Fig. 1A). Serum lipids were analyzed bymeasuring non-
esterified fatty acids (NEFA) (Wako Chemicals, Richmond, VA)
and TAG (Sigma, St. Louis, MO). ELISA kits were used
to detect serum insulin (Mercodia, Uppsala, Sweden; Cat
10-1247-01) and serum corticosterone (Enzo Life Sciences,
Farmingdale, NY; Cat ADI-900-097). Manufacturer’s recom-
mended protocols were used for all measurements.
Liver Substrate Storage
Intrahepatic glycogen and TAGwere measured in liver lysates.
Liver glycogen.Roughly 15 to 30mg of frozen powdered
tissue was used to measure glycogen content using a commer-
cially available kit (Abcam ab65620, Cambridge, MA) ac-
cording to the manufacturer’s instructions.
Liver TAG. Roughly 25 to 30 mg of frozen powdered tis-
sue was homogenized 2  15 s in 300 μL ice cold 5% NP-40
using a hand-held homogenizer (VWR, Radnor, PA). Tissue
homogenates were slowly heated to 95°C in a water bath for
5 min until the solution became white and then cooled at RT
for approximately 15 min. This heat-cooling procedure was
performed twice to solubilize tissue TAG. Homogenates were
centrifuged (14,000g, 2 min, RT) and supernatants were col-
lected for liver TAG content determination. A commercially
available TAG assay kit (SIGMA® CAT. TR0100) was used
to measure glycerol in these extracts as an indirect measure of
total TAG. This kit allows for determination of free glycerol,
total TAG, and true TAG (total TAG minus free glycerol):
all data are reported as true TAG.
Gene Expression
RNAwas isolated from frozen powdered liver (~10–15mg)
using an RNeasy kit (Qiagen, Germantown, MD) with pro-
teinase K digestion and on-column DNase treatment, as per
the manufacturer’s instructions. A Nanodrop ND-1000 spec-
trophotometer (Thermo Scientific, Wilmington, DE) was used
FIGURE 1—Study design and acute exercise responses. Graphical depictions of the overall study design (A) and weekly ExTr protocols (B) are provided.
Mice received either a control diet (Con) or a NPKD for 6 wk. Mice were randomly assigned to control sedentary (Con-Sed, n = 11), control ExTr (Con-ExTr,
n = 9), NPKD sedentary (NPKD-Sed, n = 10), or NPKDExTr (NPKD-ExTr, n = 9) groups.Mice were trained for 3 wk on a treadmill set at 10° incline and each
session started with a 5-min warm-up (W), followed by a progressive increase in speed until 65 min. To account for adaptations in cardiorespiratory fitness,
exercise intensity was increased weekly by increasing speed and/or duration of each stage. At the end of week 5, blood lactate (C), glucose (D), and BHB
(E) were measured before and immediately after acute exercise. Data are presented asmean ± SEM. #P < 0.05main effect of diet; $ main effect for exercise.







to measure RNA concentration and quality and 1 μg was used
to generate cDNA using an iScript cDNA synthesis kit (Bio-Rad,
Hercules, CA). Gene expression was measured by real-time PCR
on an ABI 7900HT Sequence Detection System (Life Technolo-
gies, Carlsbad, CA) using iTaq Universal SYBR Green Supermix
(Biorad; Cat 172-5124). Primer pairs were designed using Primer-
BLAST software and gene specificity of primer sequenceswas ini-
tially confirmed computationally via a BLAST search. Primer
sequences used for gene expression assays were as follows:
Cd36, 5′-GCAAAGAACAGCAGCAAAATC-3′ (forward) and
5′-TCCTCGGGGTCCTGAGTTAT-3′ (reverse); Cpt1α, 5′-TGG
TGGTGGGTGTGATATCA-3′ (forward) and 5′-CGCCACT
CACGATGTTCTTC-3′ (reverse); CrOT, 5′-CAAGAAGGAG
CTGGCAAAAG-3′ (forward) and 5′-GACACGGACCCACA
AAGTTC-3′ (reverse); Bhd1, 5′-GATTTGGGTTCTCACTG
GCC-3′ (forward) and 5′-TCGGTCACTCTTCAAGCTGT-3′
(reverse); Hmgc1, 5′-AGCAGGTGAAGATCGTGGAA-3′
(forward) and 5′-GGGAGAAACAAAGCTGGTGG-3′ (reverse);
Hmgcs2, 5′-GCATAGATACCACCAACGCC-3′ (forward) and
5′-ACTCGGGTAGACTGCAATGT-3′ (reverse); G6Pase, 5′-
CGAGGAAAGAAAAAGCCAAC-3′ (forward) and 5′-CAA
GGTAGATCCGGGACAGA-3′ (reverse); Fbpase1, 5′-GCAT
CGCACAGCTCTATGGT-3′ (forward) and 5′-CACAGGTAG
CGTAGGACGAC-3′ (reverse); Pck1, 5′-TGTCGGAAGAGGA
CTTTGAGA-3′ (forward) and 5′-CCACATAGGGCGAGTCT
GTC-3′ (reverse); Pex11α, 5′-ACAAAGAGGCCGTGGTAC
TG-3′ (forward) and 5′-TTGGATGCTCTGCTCAGTTG-3′
(reverse); Pex11β, 5′-CTATGGGCTGGAAAGTCTGG-3′
(forward) and 5′-CTCATAAGCATCACGGCTCA-3′ (reverse);
Pex14, 5′-AGCGAGTCTCTCGGAACTGA-3′ (forward) and
5′-ACCTTCTGCTGCTGCTGTCT-3′ (reverse); Pex16, 5′-TAC
TCTGCCTCGAACCTGCT-3′ (forward) and 5′-CCATGAAC
ACCTCCACACAC-3′ (reverse); Pex19, 5′-GCAAGTCGGAG
GCAGTAAGA-3′ (forward) and 5′-TCGCTGCTTTCCAGA
AGCTC-3′ (reverse). Other primer sequence information are pro-
vided as supplemental Table 2 (10.6084/m9.figshare.7732973)
in a previous report (24). Upon arrival, primers were initially
screened using a standard curve (triplicate) to ensure proper
linearity, whereas melt curves were examined to ensure they were
uniform across different standards. mRNA expression was deter-
mined using the comparative CT method (ΔΔCT) with an endog-
enous control (cyclophilin) and converted to a linear function using
a base 2 antilog transformation (2−ΔΔCT). Data are expressed
as fold change compared with the Con-Sed group.
Liver Protein Analysis
Protein lysates were prepared from frozen powdered liver
using T-PER buffer (ThermoFisher 78510) containing protease in-
hibitor cocktail and phosphatase inhibitors from Sigma-Aldrich
(St. Louis,MO).Western blot analyseswere performedusing stan-
dard PAGE-SDS as previously described (25). Primary antibodies
were as follows: ACC (3676), p-ACC (11818), AMPKα (5831),
p-AMPKα (2535), AMPKβ1/2 (4150), p-AMPKβ1 (4181),
and Pex5 (83020) from Cell Signaling; Catalase (ab16731), total
OXPHOS cocktail (ab110413), Pex19 (ab137072), and PMP70
(ab3421) from Abcam; GLUT2 (07-1402) and Pex14
(ABC-142) from EMDMillipore, and PGC-1α (sc-517380) from
Santa Cruz Biotechnology. Horseradish peroxidase-linked sec-
ondary antibodies (anti-mouse IgG Cat NXA931 and anti-
rabbit IgG Cat NA934V) were purchased from GE Healthcare
(Piscataway, NJ) and proteinswere detected using enhanced chemi-
luminescence chemistry. Reversible protein stain-MemCode
(MemC) (Thermo-Fisher 24580) was used to confirm equal trans-
fer of proteins and quantitation of these bands served as a loading
control. A ChemiDoc imaging system (Bio-Rad) was used to im-
age bands and Image Lab software (Bio-Rad) was used to quanti-
tate band intensity. Data are expressed as fold change compared
with the Con-Sed group after normalizing to MemC.
Substrate Oxidation Assays
Liver homogenates were prepared from fresh tissue using a
procedure that yields >95% intact mitochondria (24,26–28).
Using establishedmethods (26–28), complete substrate oxidation
was measured as liberation of 14CO2 from homogenates incu-
bated in the presence of [14C]radiolabeled substrates (American
Radiolabeled Chemicals, St. Louis, MO) as follows: [1-14C]
pyruvate (1 mM) was used to measure pyruvate dehydroge-
nase (PDH) activity, [2-14C]pyruvate (1 mM) was used to
measure pyruvate oxidation, [U-14C]leucine (100 μM) was
used to measure oxidation of the branch-chain amino acid leu-
cine, [1-14C]palmitate (200 μM) was used to measure fatty
acid oxidation, and [1-14C]lignocerate (25 μM) was used to
specifically measure peroxisomal fatty acid oxidation. Incom-
plete palmitate oxidation was assessed by measuring [14C]
acid-soluble metabolite (ASM) formation. Standard liquid scin-
tillation counting was used to measure 14CO2 and results were
calculated as nanomoles of substrate oxidized per gram tissue
wet weight per hour using equations previously reported (27).
Results for each substrate (except palmitate) were normalized
relative to the average value of the Con-Sed group and are
expressed as fold change versus Con-Sed in the paper.
Pancreatic Immunohistochemistry
Using formalin-fixed paraffin embedded pancreatic tissue,
5-μm sections were cut for immunohistochemistry analysis
as described (29). Initial analysis was performed using DAB
staining to quantify total pancreas area, islet fraction, and insu-
lin positive area. For insulin positive areameasurements of im-
munohistochemistry-stained pancreas sections, whole slide
imageswere analyzed in Visiopharm (Visiopharm, Høsersholm,
Denmark) software using custom pipelines to identify pancreas
tissue and DAB-positive regions. Islet architecture was exam-
ined using primary antibodies for insulin (Abcam ab7842)
and glucagon (Cell Signaling 2760). All primary antibody de-
tection was performed using Alexa Fluor secondary conjuga-
tion (Alexa 488; Alexa Fluor Plus 555).
Data Analysis
A Shapiro–Wilk normality test was initially performed on all
datasets and those that failed to exhibit a normal distribution









were subjected to a Box–Cox transformation. Once a normal
distribution was confirmed, a Grubbs test was used to identify
outliers. Bloodwork measured before and after acute exercise
were analyzed using a two-way repeated measure ANOVA
(diet acute exercise). A two-way ANOVA was used to exam-
ine group differences (diet  ExTr). Results from Bonferroni
post hoc analyses are reported only if interaction effects were ob-
served. GraphPad Prism 5 software (GraphPad Prism Software
Inc., San Diego, CA) was used for all statistical analyses and
a P ≤ 0.05 was established a priori as representing a statistically
significant difference. All data are presented as mean ± SEM.
RESULTS
Study design and acute exercise responses. Mice
were weight-matched before the dietary intervention, but upon
completion of the study body weight was significantly higher
in NPKD-fed mice (in grams): Con-Sed (31.9 ± 1.1), Con-
ExTr (30.9 ± 1.1), NPKD-Sed (37.0 ± 1.4), and NPKD-ExTr
(34.0 ± 1.4). A sufficient exercise stimulus was confirmed
by measuring blood lactate before and after acute exercise
(Fig. 1C), which showed mice in both dietary groups achieved
postexercise levels that neared the lactate threshold (4–5 mM).
Both dietary groups had similar resting blood glucose (fed-
state), which increased immediately after the acute exercise
bout (Fig. 1D). A rise in blood glucose after acute exercise
suggests the rate of appearance (Ra) of glucose exceeded the
rate of glucose disappearance (Rd) regardless of the dietary in-
tervention, which is consistent with an exercise protocol that
induced a moderate- to vigorous-intensity stimulus that did
not approach exhaustion (30,31). These observations are par-
ticularly interesting in the NPKD group because this diet had
no carbohydrate, which is consistent with the glycogen spar-
ing effects and increased gluconeogenesis that is expected dur-
ing ketoadaptation (16). Finally, as shown in Figure 1E, not
only was there a main effect of diet on circulating BHB, the
exercise stimulus also increased BHB (main effect). It is worth
noting that BHB after acute exercise in control-fed mice
approached levels observed in sedentary NPKD-fed mice
(0.20 mM vs 0.26 mM).
AMPK, PGC-1α, and mitochondrial parameters.
AMP-activate protein kinases (AMPK) are important sensors
of energy status, so we measured total and phosphorylated forms
of AMPKα (Figs. 2A and C) and AMPKβ1 (Figs. 2B and C).
Total-AMPKα, total-AMPKβ1, and phospho-AMPKβ1 ex-
hibited a main effect due to the NPKD (decrease); however,
no alterations were observed in phospho-AMPKα. The ratio
of phospho-AMPK to total-AMPK indicated no change in
AMPKβ1; however, AMPKα showed significant main effects
for both diet (higher) and exercise (lower).
Next, we tested the response of PGC-1α because it is a
downstream target of AMPK that plays a role in remodeling
numerous metabolic pathways, including mitochondrial dy-
namics. A main effect of diet was observed for PGC-1α gene
(Fig. 2D) and protein (Fig. 2C and E) content, indicating lower
PGC-1α in NPKD-fed mice. Exercise training resulted in a
main effect on PGC-1α gene expression (higher), but this
was not observed at the protein level. Although the PGC-1a
gene was responsive to both diet and ExTr, expression of the
mitochondrial transcription factor A (Tfam) was only higher
in NPKD-fed mice (Fig. 2D). Despite alterations in AMPK
and PGC-1α, no differences in electron transport chain com-
plex proteins were observed (Fig. 2C and F). Likewise, few
differences were detected in expression of genes involved in
mitochondrial fission and fusion (Fig. 2G), with the exception
being a main effect of diet onOpa1 (higher). Overall, these re-
sults suggest the NPKD produced inhibitory remodeling of
major regulators of energy sensing pathways and substrate
metabolism (i.e., AMPK and PGC-1α) in liver. Importantly,
although ExTr generally did not override the inhibitory effects
of the NPKD on AMPK and PGC-1α, the NPKD did not neg-
atively impact electron transport chain content.
Liver glucose metabolism. Blood glucose at harvest
did not differ due to the NPKD or ExTr (24 h after exercise
cessation) (Fig. 3A). Again, this is noteworthy because mice
in the NPKD group were fed a diet devoid of carbohydrate.
Because liver plays a primary role in maintaining glucose ho-
meostasis, we tested if differences in hepatic pathways related
to glucose homeostasis were consistent with maintenance of
circulating glucose in response to the NPKD and ExTr. He-
patic glycogen reserves displayed main effects of diet and ex-
ercise and results point toward both interventions lowering
hepatic glycogen (Fig. 3B). We next tested the capacity to uti-
lize carbohydrate as fuel. The NPKD-fed mice had signifi-
cantly lower PDH activity (Fig. 3C) and pyruvate oxidation
(Fig. 3D), whereas ExTr had lower pyruvate oxidation only
in mice fed the control diet (Fig. 3D). PDH kinase 4 (Pdk4)
is a lipid-responsive gene that moderates a substrate switch
that favors lipid utilization to spare glucose; therefore it is sur-
prising that Pdk4 gene expression was lower in the lipid-
enriched, carbohydrate-deficient NPKD groups (main effect)
(Fig. 3E). We next tested genes related to gluconeogenesis.
Main effects for diet and exercise indicated both NPKD and
ExTr groups had lower expression ofG6Pase (Fig. 3F). Alter-
natively, Pck1 was higher after ExTr in control-fed mice, but
this was negated in NPKD-fedmice (interaction effect). Finally,
neither the NPKD nor ExTr altered GLUT2 protein, which is
the predominant glucose transporter in liver (Fig. 3G). Together
these findings indicate the liver responds to a NPKD by reduc-
ing oxidative capacity to utilize carbohydrate-derived fuels;
however, the tissue does not appear to enhance gluconeogenic
pathways or increase glycogen storage as a defense to preserve
circulating glucose.
Endocrine parameters. Circulating corticosterone did
not differ in mice fed a NPKD; however, levels of this gluco-
corticoid were lower in ExTr mice (Fig. 4A). Similar to blood
glucose (Fig. 3A), serum insulin did not differ in either the
NPKD or ExTr groups (Fig. 4B). The NPKD mice had signif-
icantly smaller islet fraction (Fig. 4D), but the diet appeared to
have no impact on total pancreas area (Fig. 4C) or insulin pos-
itive area (Fig. 4E). Because previous studies show high-fat
and western style diets (high-fat/high sucrose) induce robust







increases in islet size and insulin positive area (32,33), our data
suggest the proliferative response is either driven primarily by
carbohydrate content (rather than solely by excess dietary
lipid) or by a combination of carbohydrate plus lipid. We note
ExTr had no impact on islet fraction (Fig. 4D); however, total
pancreas area was lower (Fig. 4C), whereas insulin positive
area was higher in ExTr mice (Fig. 4E). These findings are
similar to other studies showing ExTr increases islet insulin
content (34,35). Immunofluorescent staining for insulin and glu-
cagon show no gross differences in islet architecture amongst any
of the interventions (Fig. 4F). Collectively, results indicate
mice respond well to both exercise and dietary conditions fa-
voring ketogenesis with no adverse consequences to cortico-
sterone, insulin, or islet morphology.
Fatty acid, amino acid, and ketonemetabolism.Be-
cause this study utilized a diet that provided 83.9% of energy
from fat and 0% energy from carbohydrate, we tested path-
ways related to lipid metabolism and ketogenesis. Despite sub-
stantial dietary lipid, circulating NEFA (Fig. 5A) and TAG
(Fig. 5B) were not different due to diet or ExTr. Alternatively,
intrahepatic TAG were higher (main effect) in NPKD-fed
mice (Fig. 5C). Interestingly, despite the fact that no main
effect of ExTr was detected, an interaction effect was observed
that showed a pattern for ExTr to increase hepatic TAG in
control-fed mice, but decrease TAG in NPKD-fed mice. A
lipid-enriched NPKD increased gene expression of a primary
plasmalemmal fatty acid transporter, Cd36; however, ExTr
had no effect (Fig. 5D). Main effects of both NPKD (de-
creased) and ExTr (increased) were found for the acetyl-CoA
carboxylase 1 (Acc1) gene (Fig. 5D), whereas only the diet effect
(decreased) was observed for total- and phospho-ACC protein
(Fig. 5E). Active (unphosphorylated) ACC converts acetyl-
CoA to malonyl-CoA, which serves as a precursor for de novo
lipogenesis and allosterically inhibits mitochondrial lipid en-
try; therefore, we measured mitochondrial fatty acid oxidative
capacity. Data show NPKD-fed mice had higher incomplete
palmitate oxidative capacity (Fig. 5F) and expression of
key genes (Cpt1α, Cact, and Cpt2) involved in mitochon-
drial lipid entry (Fig. 5G). Alternatively, ExTr had a main effect
showing slightly lower incomplete palmitate oxidation (Fig. 5F).
Importantly, incomplete lipid oxidation in liver primarily rep-
resents ketone production (36). Because complete oxidation
FIGURE 2—AMPK, PGC-1α, and mitochondrial adaptations. Conventional energy sensing protein kinases, AMPKα (A) and AMPKβ1 (B), were mea-
sured byWestern blotting (WB) using liver protein lysates. Representative images of both AMPKα and AMPKβ1 (phospho- and total) are shown in panel
C. Examination of factors involved in mitochondrial biogenesis was tested by measuring expression of PGC-1α and Tfam gene expression (D) PGC-1α pro-
tein (E), protein levels of subunits involved in Complex I-V of the electron transport system (F) and expression of genes involved inmitochondrial fission and
fusion (G). Data are presented asmean ± SEM.QuantitatedWestern blots images and gene expression are normalized to total protein stain usingMemCode
(MemC) and cyclophilin (PPIB), respectively. #P < 0.05 main effect of diet; $ main effect for exercise.









(CO2) did not differ due to diet or exercise, results likely rep-
resents a liver with greater ketogenic potential in NPKD-fed
mice, whereas this is slightly lower with ExTr.
Although greater hepatic capacity to produce ketones from
lipid substrates likely contributes to the higher circulating BHB
in the NPKD group (Fig. 1E), ketones can also be derived from
certain amino acids. Tyrosine, threonine, isoleucine, phenylala-
nine, and tryptophan are considered to be both gluconeogenic
and ketogenic, whereas lysine and leucine are described as solely
ketogenic. With this in mind, leucine oxidation was measured
to test hepatic metabolism of a ketogenic amino acid. Consistent
with higher ketogenesis, NPKD-fed mice had higher leucine
oxidative capacity (Fig. 5H). Alternatively, leucine oxidation
was similar in ExTr groups. Differences in leucine oxidative ca-
pacity could not be ascribed to regulation of key genes involved
in branched-chain amino acid metabolism (Fig. 5I). However,
greater ketogenic potential of NPKD-fed mice was supported
when measuring key genes involved in ketogenesis (Fig. 5J).
ExTr appeared to normalize expression of the D-BHB dehy-
drogenase 1 (Bdh1) gene in NPKD-fed mice, but had no effect
on the other ketogenic genes.
Peroxisomal metabolism. Peroxisomes play a critical
role in several lipid metabolism pathways, so we assessed per-
oxisomal adaptations in response to a NPKD and ExTr. Al-
though mitochondria cannot process lipids with a chain
length greater than 20 carbons, peroxisomes are uniquely ca-
pable of catabolizing very long chain fatty acids. As such, ox-
idation of lignocerate (C24:0) was used to assess peroxisomal
function. As shown in Figure 6A, a main effect indicates per-
oxisomal oxidative capacity was significantly elevated by the
NPKD. Alternatively, ExTr did not alter hepatic peroxisomal
fat oxidation (Fig. 6A). The diet-induced increase in peroxi-
somal oxidation could not be explained by differences in pro-
tein levels of key peroxisomal markers (Fig. 6B). Similarly, a
main effect of diet was only observed in gene expression of car-
nitine octanoyltransferase (CrOT) and peroxin 16 (Pex16),
whereas no other peroxisomal genes were specifically altered
by the NPKD (Fig. 6C). Interestingly, however, despite the fact
that relatively few main effects were observed (diet or exercise),
several peroxisomal genes (CrOT, catalase,Pex3,Pex5,Pex11a,
and Pex11b) had a significant interaction effect between diet and
exercise. Based upon the gene expression pattern, it seems the
NPKD alone tended to increase peroxisomal genes; however,
the effects of ExTr were to increase peroxisomal genes in
control-fed mice, but reduce them in NPKD-fedmice. Overall,
results suggest that 1) an NPKD increases peroxisomal fat ox-
idation, and 2) although moderate- to vigorous-intensity ExTr
alone is insufficient to induce peroxisomal remodeling in liver
of control-fed mice, ExTr may be capable of normalizing per-
oxisomal function in NPKD-fed mice.
DISCUSSION
With growing interest in KD as therapeutic and ergogenic
aids, it is important to understand how they impact endocrine
and metabolic outcomes. Rodents are the most commonly used
model in biomedical research because they provide the ability
to perform mechanistic examinations that are not feasible in
humans. Unfortunately, the vast majority of literature testing
the effects of a KD in rodents have used a low-protein KD
(11,12,18–20), which does not mirror the normal- to high-
protein KD most commonly consumed by humans (16,17,21).
Also, most reports using rodents to test exercise adaptations in
liver focus on models of metabolic disease, whereas the effects
of ExTr in a healthy population have largely been overlooked.
As such, the purpose of this study was to test substrate metabo-
lism pathways in lean, healthy mice in response to ExTr while
being fed a high-fat, carbohydrate-deficient KD that had normal
FIGURE 3—Liver glucose metabolism. Adaptations from diet and/or ExTr of liver glucose metabolism were studied by measuring blood glucose (A) and
hepatic glycogen content (B) from samples collected at tissue harvest (2–4 h food pull). PDH activity (C) and pyruvate oxidation (D) were measured in liver
homogenates. Expression of genes involved in carbohydrate (E) and gluconeogenesis (F) were assessed by RT-PCR. GLUT2 protein was measured by west-
ern blot (G). Data are presented asmean ± SEM.RT-PCR data are normalized to cyclophilin (PPIB), whereas protein blots were normalized to total protein
stain MemCode (MemC). #P < 0.05 main effect of diet; $ main effect for exercise; Int Interaction effect; Bonferroni post hoc test revealed significant differ-
ences (identified with an asterisk) at the following P values **P < 0.01; ***P < 0.001.







protein content (NPKD). Our primary focus was to test responses
in liver due to its role in gluconeogenesis and ketogenesis, but we
also examined the pancreas due to its role in regulating glucose
homeostasis. To our knowledge, this is the first study to compre-
hensively test mitochondrial and peroxisomal substrate oxidative
capacity (carbohydrate, amino acid, and lipid) in liver of lean,
healthy mice in response to ExTr while on a NPKD.
Mice have a robust gluconeogenic capacity, allowing them to
process noncarbohydrate carbon sources (chiefly amino acids)
to maintain blood glucose under conditions of carbohydrate
deficit (37). Results herein support this notion as mice that
consumed a carbohydrate-deficient NPKD maintained blood
glucose at rest and during strenuous exercise. Feeding a NPKD in-
duced a 6.5-fold increase in circulating BHB, confirming that it
drove ketogenesis; however, absolute concentrations (~0.24 mM)
are lower than other models of nutritional ketosis, which has
been defined as ketones ≥0.5 mM (16). Induction of mild nutri-
tional ketosis in this study is likely due to provision of enough
dietary protein to adequately support gluconeogenesis, thus lim-
iting need to mobilize endogenous protein sources. In support,
Bielohuby et al. (38) showed that protein content in a KD is
an essential determining factor for ketosis in rodents as rats
fed a low-protein KD (5.5% energy as protein) had robust
nutritional ketosis, whereas those fed a moderate protein KD
(11.8% energy as protein) had modest ketogenesis, and those
fed a high-protein KD (19.1% energy as protein) had little
change in ketones. With this in mind, most rodent studies to
date appear to have aimed to maximize nutritional ketosis as
they have used a low-proteinKD (11,12,18–20). In our view, there
are pitfalls to this approach. Low-protein diets (i.e., nonketogenic)
alone increase energy expenditure, reduce body weight, and
improve glucose homeostasis; however, mechanisms that me-
diate these benefits do not always overlap with KD in humans.
For example, low-protein diets induce FGF21, which imparts
health benefits (20,22,39), yet normal- to high-protein KD
consumed most commonly by humans do not induce FGF21
in rodents or humans (21,38). In addition, many tissues rely on
amino acid consumption to support energetic and other needs
(e.g., growth) (40). Thus, maintaining a normal to high level
of dietary protein prevents growth deficits, spikes in FGF21,
and other metabolic alterations. Nuances, such as protein con-
tent in KD, can make it difficult to translate findings from ro-
dents to humans. Results, herein, show that an NPKD-induced
mild nutritional ketosis and the adaptations are independent of
the effects of protein restriction; therefore, we feel this study
offers novel insights relevant to human physiology.
FIGURE 4—Endocrine adaptations to NPKD and ExTr. Serum corticosterone (A) and serum insulin (B) were measured at terminal harvest. Total pan-
creatic area (C), islet fraction (D), and insulin positive area (E) were measured by immunohistochemistry using DAB staining. Representative islet images
show normal islet α-cell and β-cell morphology in response to diet and exercise (F). Scale represents 100 μm. Data are presented as mean ± SEM. #P < 0.05
main effect of diet; $ main effect for exercise.









The NPKD actually produced many predicted changes in
metabolic pathways in liver that are similar to a low-protein KD,
including lower carbohydrate utilization, higher use of a ketogenic
amino acid (leucine), and higher lipid utilization (mitochondrial
and peroxisomal). Shifts in substrate metabolic capacity in
NPKD-fed mice occurred despite a decrease in PGC-1α and no
difference in mitochondrial content, which is similar to findings
using a low-protein KD (14,19,41). Mice fed the lipid-enriched
NPKDhadhigher intrahepatic TAG,which also seems to occur re-
gardless of the amount of dietary protein (11,12); however, the de-
gree of steatosis observedwithKD is likely less than that seenwith
a traditional high-fat “western” diet (42). In contrast, a notable
difference between the NPKD used herein compared with lit-
erature using a low-protein KD is the response of AMPK.
Studies using a low-protein KD report activation of AMPK
(11,14), whereas findings in the present study show lower total
and phosphorylated AMPK. These findings are reminiscent of
the differential response of FGF21 due to protein content in
KD (38). This is perhaps not surprising considering the fact that
AMPK and FGF21 are both activated in response to nutritional
stress and a carbohydrate-deficient, low-proteinKD is almost cer-
tain to impose a greater metabolic stress on liver than a NPKD.
Using models of liver disease, researchers have shown that
ExTr can increase hepatic oxidative capacity and reduce steatosis
FIGURE 5—Fatty acid, amino acid, and ketonemetabolism. SerumNEFA (panel A), andTAG (B) weremeasured from blood obtained at the time of tissue
collection (2–4 h food pull). Parameters related to hepatic lipid storage were tested by measuring liver TAG content (C), expression of Cd36 and Acc1 genes
involved in lipid uptake and storage (D), as well as protein content and phosphorylation status of acetyl-CoA carboxylase (ACC; panel E). Factors related to
tissue lipid oxidation were examined bymeasuring complete (CO2) and incomplete (ASM) palmitate oxidation (F), as well as expression of genes involved in
mitochondrial fatty acid transport (G). Branched chain amino acid metabolism was studied by assessing leucine oxidation (H), as well as expression of the
Bcatm and Bckhd genes (I). Bhd1, Hmgcl, and Hmgcs2 genes (J) were measured as representative genes involved in ketogenesis. Data are presented as
mean ± SEM. RT-PCR data were normalized to cyclophilin (PPIB), whereas protein blots were normalized to total protein stain MemCode (MemC).
#P < 0.05 main effect of diet; $ main effect for exercise; Int Interaction effect; Bonferroni post hoc test revealed significant differences (identified with an
asterisk) at the following P values: **P < 0.01; ***P < 0.001; ****P < 0.0001.







(8–10); however, less is known about ExTr adaptations in liver
of healthy subjects. Results herein indicate that despite the fact
that the exercise protocol provided a stimulus sufficient to near
the lactate threshold (4–5 mM) and increase circulating BHB to
levels similar to a NPKD (i.e., vigorous-intensity), differences
in metabolic pathways were not overly robust. PGC-1α is
highly involved in adaptations to ExTr as this transcriptional
coregulator can increase mitochondrial content (43), enhance
peroxisomal biogenesis (25), and is a central modulator of glu-
coneogenesis (44). PGC-1α gene expression was modestly
higher in ExTr mice in the present study; however, no evi-
dence of altered mitochondrial or peroxisomal content was ob-
served. Alternatively, ExTr cohorts had lower hepatic glycogen
content, pyruvate oxidation, and incomplete palmitate oxidation
(ASM), whereas Pck1 gene expression was higher in mice fed
the control diet. Because blood glucose levels were not compro-
mised during exercise, these results may indicate that 1) the
liver likely adapted to become more efficient at providing
the body with substrates required during exercise (glucose
and ketones), and/or 2) the whole organism adapted to more
efficiently use lipid as fuel, thus decreasing reliance on carbo-
hydrates (i.e., ketoadaptation). Moreover, there were no major
differences in corticosterone, insulin, or islet morphology,
showing that the major endocrine factors regulating macronu-
trient metabolism were largely unperturbed by the dietary and
exercise interventions used.
Ketogenesis is traditionally thought of as a response to pro-
longed fasting that occurs to provide an alternate fuel source to
spare glucose when glycogen is depleted. This physiological
relationship has led to the common belief that hepatic glyco-
gen content is depleted in response to a KD; however, the
NPKD in this study showed a more modest decrease in liver
glycogen. In truth, there is a relative paucity of information
in the literature to support the notion that KD deplete liver gly-
cogen; therefore, this claim seems to be driven more by popu-
lar media, rather than an abundance of scientific evidence.
With this in mind, during ketoadaptation, the body adapts to
preferentially use fatty acids while sparing glucose (15,16),
and our results are consistent with this concept. Second, sub-
jects fed a KD exhibit a glycogen sparing effect during exercise,
and the presence of ketones facilitates glycogen recovery after
an exercise bout (16,45). Third, after acute exercise that nearly
depletes liver glycogen, mice completely restore these reserves
within 3 h despite having no access to food (24). Given this ro-
bust gluconeogenic potential, mice in this study had ample time
(samples collected 24 h after last exercise bout) to restore glyco-
gen despite being provided a carbohydrate-deficient NPKD.
Together, these results support the notion that ketoadaptation
modulates liver function to protect glycogen reserves,
which contradicts the popular notion that KD deplete he-
patic glycogen. It is, however, worth noting that due to their
inherently high gluconeogenic capacity, mice have lower gly-
cogen stores than rats or humans (37); thus, glycogen would
be more rapidly replenished in mice. Also, the NPKD used
in this study only induced mild nutritional ketosis; therefore,
it is possible that a KD that induces more robust increases in
nutritional ketosis would be associated with more severe de-
pletion of liver glycogen. As such, further investigation is
likely required to better define the relationship between vari-
ous KD and hepatic glycogen content, and whether studies
using mouse models in this particular area of inquiry translate
well to humans.
AMPK and PGC-1α were lower in NPKD-fed mice and
levels were not rescued by ExTr. This is somewhat surprising
because low-protein KD and ExTr have been reported to in-
crease AMPK and PGC-1α (11,14). With this in mind, it
FIGURE 6—Hepatic peroxisomal oxidation is higher inNPKD-fedmice. Peroxisomal fat oxidationwas tested bymeasuring oxidation of the very long chain
fatty acid (C24:0), lignocerate (A) in liver homogenates. Peroxisomal proteins (B) and genes (C) were measured and protein images were normalized to total
protein usingMemCode (MemC), whereas gene expression was normalized to cyclophilin (PPIB). Data are presented as mean ± SEM. #P < 0.05main effect
of diet; $ main effect for exercise; Int Interaction effect; Bonferroni post hoc test revealed significant differences (identified with an asterisk) at the following
P values: **P < 0.01; ****P < 0.0001.









seems that the metabolic state induced by a NPKD is sufficient
to actually limit activation of these energy sensing pathways.
Additionally, significant interactions between diet and exer-
cise were observed for liver TAG, as well as genes involved
in gluconeogenesis (Pck1), ketogenesis (Bdh1), mitochondrial
fat oxidation (Cact), and several peroxisomal markers (CrOT,
Catalase, Pex3, Pex5, Pex11α, and Pex11β); however, none of
these interactions suggest an additive/synergistic relationship,
as predicted. Rather, in each instance the interaction effects
showed that the NPKD and ExTr adaptations were opposing each
other. A possible explanation is that ExTr while on aNPKD accel-
erated ketoadaptation inmuscle (and other tissues) to becomemore
reliant on free fatty acids as metabolic fuel, thus requiring less
ketogenic and gluconeogenic potential in the liver; however,
further studies would be required to validate this contention.
Overall, results from this study suggest the liver likely re-
sponds to a NPKD by limiting carbohydrate utilization path-
ways and increasing ketogenic potential by enhancing utilization
of ketogenic substrates (lipid and ketogenic amino acids). Re-
sults also suggest that the response of substrate metabolism
pathways to a NPKD appear to be similar to those reported
in the literature using a low-protein KD, with the notable ex-
ception being lower total and phosphorylated AMPK with
the NPKD. These results seem to suggest that protein content
of a KD may play a role in activation of energy sensing path-
ways in the liver. Interestingly, despite the fact that ExTr can
activate AMPK, the training regimen used in the present study
did not override the decrease in AMPK or PGC-1α induced by
the NPKD. Additionally, despite findings suggesting that mice
exercised at a vigorous-intensity, ExTr alone hadminimal impact
on most metabolic pathways. In contrast to our hypothesis, ExTr
and a NPKD did not appear to exert additive/synergistic remod-
eling of the hepatic substrate metabolism pathways tested, but
instead seemed to counter the effects of each other. Whether
these effects can be at least partially attributed to ketoadaptation
in other tissues that limit reliance on hepatic gluconeogenesis
and/or ketogenesis warrants further study.
LIMITATIONS
C57BL/6J mice were used because they are the most
common mouse model in scientific research and are prone
to high-fat diet-induced metabolic dysfunction. However, this
strain has an inherent deficiency of nicotinamide nucleotide
transhydrogenase, which has an important role in peroxide de-
toxification (46). Also, the ExTr response of C57BL/6J mice
is similar to Balb/C mice, but is less robust than Friend leuke-
mia virus B mice (47). As such, we cannot rule out the possi-
bility that responses to NPKD and ExTr may differ in other
mouse strains.
A second limitation is that all mice were exercised at the
same absolute intensity.With this inmind, mice fed the NPKD
were heavier than control-fed mice, so they experienced a greater
workload; therefore, it could be argued that NPKD-fed mice
exercised at a higher relative intensity. Although we cannot en-
tirely rule out this possibility, the fact that postexercise blood
lactate, glucose, and BHB were similar between the dietary
groups, and results from the study generally did not reveal
many differential responses to ExTr in mice fed the control
versus NPKD diets, suggest differences in relative exercise in-
tensity were not likely to be robust.
A third limitation is that although blood lactate was used to
gauge exercise intensity, lactate is also an efficient gluconeogenic
substrate. As such, it is possible that mice fed a carbohydrate-
deficient NPKD converted lactate to glucose faster than control-
fed mice. Not only could this alter the interpretation of exercise
intensity between groups but it may also help explain how
NPKD-fed mice maintained blood glucose throughout exercise
despite having modestly lower hepatic glycogen and greater
workload. In this regard, however, it is worth noting that in-
spection of genes involved in gluconeogenesis, pancreatic
hormones that regulate glucose, and circulating glucose sug-
gested the inherent gluconeogenic capacity was sufficient to
maintain blood glucose during exercise. Future studies using
stable isotope tracers would be ideal to address this matter.
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